Alnylam Pharmaceuticals
ALNY
#833
Rank
$29.42 B
Marketcap
$219.89
Share price
0.08%
Change (1 day)
-51.35%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company